ONMD

OneMedNet Corporation

OneMedNet Corporation (ONMD) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (A); its weakest is Momentum (C-). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
B-
Factor Score 2.9 / 5.0
Growth
A
Factor Score 4.4 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
C-
Factor Score 1.9 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -3.2
Rev Growth YoY 88.4%
Gross Margin -83.3%
Price Return 3M -12.5%
Price Return 12M -64.6%
Catalyst Signal 0.00
Market Cap $31.1M
TTM Revenue $1.5M
Price / Sales 21.4
ROE N/A

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (2.9) A (4.4) C- (1.9) C- (1.9) C+ (2.6) C+ (2.8)
2026-11-07 B- (2.9) A (4.4) C- (1.9) D+ (1.6) C+ (2.7) C+ (2.7)
2026-10-31 B- (2.9) A+ (4.5) C- (2.0) D- (1.1) C+ (2.7) C+ (2.6)
2026-10-24 B- (2.9) A (4.5) C- (1.9) D+ (1.6) C+ (2.6) C+ (2.7)
2026-10-17 B- (2.9) A (4.5) C- (1.9) D (1.5) C+ (2.6) C+ (2.7)
Page 1 of 4